Long-Term Liabilities: The sum of all non-current liabilities.
vTv Therapeutics Inc. (VTVT) had Long-Term Liabilities of $18.79M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-8.70M |
|
-- |
|
-- |
|
$10.70M |
|
$-10.70M |
|
$0.35M |
|
$-10.35M |
|
$-10.35M |
|
$-10.35M |
|
$-10.35M |
|
$-10.35M |
|
$-10.35M |
|
$-10.70M |
|
$-10.70M |
|
8.06M |
|
8.06M |
|
$-1.08 |
|
$-1.08 |
|
| Balance Sheet Financials | |
$99.46M |
|
$0.01M |
|
$0.04M |
|
$99.49M |
|
$10.16M |
|
-- |
|
|
Long-Term Liabilities |
$18.79M |
$28.95M |
|
$70.54M |
|
$70.54M |
|
$70.54M |
|
3.94M |
|
| Cash Flow Statement Financials | |
$-16.00M |
|
-- |
|
$77.76M |
|
$36.75M |
|
$98.50M |
|
$61.76M |
|
$2.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.79 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.66% |
|
-14.66% |
|
-10.40% |
|
-14.66% |
|
$17.91 |
|
$-1.99 |
|
$-1.99 |
|